Abstract: The potential for cross-talk between the adenyl cyclase and phosphoinositide (PPI) lipid second messenger system was investigated in astrocytes cultured from neonatal rat brain. Glutamate-stimulated PPI turnover, measured by the formation of total inositol phosphates from myo-[3H]inositol-labeled lipids, was inhibited in a concentrationdependent manner by the elevation of intracellular cyclic AMP levels produced either by stimulation of the isoproterenol receptor linked to adenyl cyclase or by its direct activation by forskolin. N6,2'-O-Dibutyryl cyclic AMP, an analogue that can also activate cyclic AMP-dependent kinase, inhibited glutamate-stimulated PPI turnover in a concentration-dependent manner as well, a result suggesting that cyclic AMP-dependent kinase is involved in mediating the inhibi- Evidence is accumulating that astrocytes are important in controlling the chemical environment of the brain. This regulation appears to be mediated, at least in part, by direct interaction of neurotransmitters and trophic factors with glial membranes, leading to various cellular responses, including ion transport, neurotransmitter uptake and release, and changes in membrane potential (Drejer et al., 1982; Kettenmann and Schachner, 1985; Kimelberg et al., 1986; Shain et al., 1986) . The excitatory amino acid glutamate is a neurotransmitter that may play such a role.
Abstract: The potential for cross-talk between the adenyl cyclase and phosphoinositide (PPI) lipid second messenger system was investigated in astrocytes cultured from neonatal rat brain. Glutamate-stimulated PPI turnover, measured by the formation of total inositol phosphates from myo-[3H]inositol-labeled lipids, was inhibited in a concentrationdependent manner by the elevation of intracellular cyclic AMP levels produced either by stimulation of the isoproterenol receptor linked to adenyl cyclase or by its direct activation by forskolin. N6,2'-O-Dibutyryl cyclic AMP, an analogue that can also activate cyclic AMP-dependent kinase, inhibited glutamate-stimulated PPI turnover in a concentration-dependent manner as well, a result suggesting that cyclic AMP-dependent kinase is involved in mediating the inhibition. Inclusion of an inhibitor of cyclic AMP-dependent kinase, I-(5-isoquinolinesulfonyl)-2 methylpiperazine dihydrochloride or N-(2-guanidinoethyl)-5-isoquinolinesulfonamide hydrochloride, blocked the cyclic AMP-mediated inhibition in a concentration-dependent manner, a finding further supporting this hypothesis. The site of inhibition of the phosphoinositol lipid pathway by cyclic AMP was probed using a digitonin-permeabilized cell system. Guanosine 5'-0-(3-thiotriphosphate), a nonhydrolyzable analogue of GTP, stimulated PPI turnover and potentiated glutamate-stimulated PPI turnover, and guanosine 5'-0-(3-thiodiphosphate) inhibited glutamate-stimulated PPI turnover in these cells, results providing evidence that glutamate receptors are coupled to phospholipase C by a guanine nucleotide binding protein in astrocytes. N6,2'-O-Dibutyryl cyclic AMP and agents that elevate cyclic AMP levels inhibited the PPI turnover stimulated by guanosine 5'-0-( 3-thiotriphosphate), as Evidence is accumulating that astrocytes are important in controlling the chemical environment of the brain. This regulation appears to be mediated, at least in part, by direct interaction of neurotransmitters and trophic factors with glial membranes, leading to various cellular responses, including ion transport, neurotransmitter uptake and release, and changes in membrane potential (Drejer et al., 1982;  Kettenmann and Schachner, 1985;  Kimelberg et al., 1986; Shain et al., 1986) . The excitatory amino acid glutamate is a neurotransmitter that may play such a role.
Glutamate can directly depolarize the membranes of astrocytes in culture (Bowman and Kimelberg, 1984 ; Kettenmann and Schachner, 1985) , and the coupling of glutamate to the receptor-activated phosphoinositide (PPI) lipid second messenger system was demonstrated by Pearce et al. (1 986a) in studies where glutamate stimulated the formation of inositol phosphates (IPS) from PPI lipids.
Astrocytes also possess receptors that are coupled to the regulation of adenyl cyclase and production of cyclic AMP, the other major cellular signal transduc-tion pathway (McCarthy and de Vellis, 1978; Henn and Henn, 1980; Van Calker et al., 1983; Evans et al., 1984) . Best studied of these is the 0-adrenergic receptor, which may be involved in the metabolism of glial glycogen, important in the regulation of CNS energy stores (Cummins et al., 1983) .
Recent evidence indicates that these two second messenger systems can play interconnected roles in mediating cellular behavior, although their mutual influences vary widely among different cells and tissues (Kaibuchi et al., 1982; France1 et al., 1987; Hill and Kendall, 1987; Madison and Brown, 1988; Laufer and Changeux, 1989) . Defining the nature and molecular mechanisms of such potential cross-talk is important for understanding the ultimate functional responses of cells.
Therefore, the present study was undertaken to investigate the influence of cyclic AMP on glutamatestimulated PPI lipid turnover in cultured neonatal rat astrocytes. Our results indicate that the elevation of intracellular cyclic AMP levels, either by receptorstimulated or direct activation of adenyl cyclase, resulted in dose-dependent inhibition of glutamate-stimulated PPI lipid hydrolysis in these cells. N6,2'-0-Dibutyryl cyclic AMP (dBcAMP), an analogue that, like cyclic AMP, activates cyclic AMP-dependent kinase (A-kinase), also inhibited glutamate-stimulated PPI turnover, a result suggesting that this pathway, probably through A-kinase-directed phosphorylations, is involved in mediating the inhibition by all of these agents.
A digitonin-permeabilized cell system was used to investigate the mechanism by which stimulation of the glutamate receptors is linked to phospholipase C and PPI hydrolysis in astrocytes. We found that guanosine 5'-0-(3-thiotnphosphate) (GTP[S]), a nonhydrolyzable analogue of GTP, stimulated the formation of 3H-IP from rnyo-[3H]inositol-prelabeled PPI lipids and potentiated the PPI turnover stimulated by glutamate, as well, a finding providing evidence that glutamate receptors are coupled to phospholipase C by a GTP binding protein (Gs protein).
In the permeabilized astrocytes, isoproterenol, forskolin, and dBcAMP, each inhibited the formation of 3H-IP stimulated by GTP [S] , as well as the 'H-IP formation stimulated by glutamate and potentiated by GTP [S] . These data suggest that elevation of cyclic AMP levels inhibits glutamate-stimulated PPI hydrolysis by interfering at or distal to the G, protein that links the glutamate receptor to phospholipase C in astrocytes. 
MATERIALS AND METHODS

Materials
Cell culture
Astrocyte cultures were prepared from neonatal rat brain according to a modification of a previously described method (Frangakis and Kimelberg, 1984; . The cells were used at confluence, 7-10 days after first passage, and were 90-95% positive on immunocytochemical staining for glial fibrillary acidic protein, a specific astrocyte marker.
Measurement of PPI turnover
Intact cells. Intact, confluent, first-passage astrocyte cultures in six-well multiplates were prelabeled for 48 h with 10 pCi of my0-[2-~H]inositol (1 5 Ci/mmol) in 1 ml of serum-free DMEM. Inositol-free medium was not used for the prelabeling as described previously , because no significant difference in labeling was found using DMEM containing inositol. Labeling medium was removed, and the cells were incubated with various agents and 5 mM LiCl, in a final volume of 1 ml of DMEM, at 37OC usually for 10 min. Reactions were stopped by addition of 1 ml of 10% cold trichloroacetic acid to the wells, after which the cells were scraped into the medium. The cell suspension was centrifuged, and the deproteinized supernatant was washed six times, each with 3 ml of water-saturated ether, and neutralized with 1 M KHC03. The total IP fraction was separated and quantified by ion exchange chromatography as previously described (Robertson et al., manuscript in preparation) .
Permeabilized cells. After the period of prelabeling with my~-[~H]inositol, intact cells in multiwells were permabiked by a modification of a procedure described by Eberhard and Holz (1987) . After a 10-min incubation with 1 ml of a buffer containing 139 mM potassium monophosphate, 2 mM ATP, 4 mM MgC12, 5 mM LiCI, 10 mM EGTA, 20 p M digitonin, and 30 mMsodium HEPES (pH 7.4 at 37"C), the cells were rinsed twice with the same buffer minus digitonin and containing concentrations of CaClz to achieve Caz+/EGTA molar ratios between 0.0 and 5.5 for the experiments determining the CaZ+ sensitivity of the agonists. In the other experiments, the Ca*+/EGTA ratio was maintained at 0.5 (corresponding to 800 &free (3"). Free Ca" concentrations in the various buffers were determined fluorometrically with fluo-3 as the indicator.
After incubation at 37OC for the indicated times (usually 30 min) in the same Ca2+-containing buffer with agonists, the release of total 'H-IPS was measured by addition of 1 ml of ice-cold 10% trichloroacetic acid to the medium, which had been rapidly removed from the wells. Extraction, sepa-ration, and quantification of the phosphates were performed in the same way as for the intact cells. In experiments where the effects of dBcAMP, isoproterenol, or forskolin on PPI turnover were being measured, the prelabeled cells were incubated with these agents for 10 rnin at 37°C before permeabilization. Release of labeled phosphates was then measured after permeabilization and incubation with the agonists. In some experiments, the inhibitory agents were added after the cells had been permeabilized, simultaneously with the agonists. ARer permeabilization, the cells had a normal appearance by light microscopy, which was maintained throughout the period of stimulation by agonist.
RESULTS
In astrocytes prelabeled with myo-['H]inositol and permeabilized with digitonin, glutamate or glutamate plus 100 pMGTP[S] combined each stimulated a concentration-dependent release of 'H-IP (Fig. 1) . Total 'H-IP content was measured in all experiments after it had been determined that the glutamate-stimulated increase in 'H-IP at 10 and 30 min was predominantly present as ['HIIP, (72 GDPpS is a metabolically stable analogue of GDP that has been used extensively as a competitive antagonist of guanine nucleotide binding protein activation (Eckstein et al., 1979; Brass et al., 1986) . Addition of GDPpS to astrocytes made permeable by digitonin inhibited the glutamate-stimulated release of 'H-IP (Fig.  3) . The Ki (1.47 mM) for this inhibition of glutamatestimulated 'H-IP release by GDPSS was very close to that for inhibition of 'H-IP release stimulated by GTP [S] (1.35 mM) .
The potential role of free Ca" in the regulation of phospholipase C was assessed in permeabilized astrocytes. Raising the free Ca2+ concentration from <10 to 800 nM resulted in a modest ( 160% of control values) increase in 'H-IP release (Fig. 4) Basal levels of 3H-IP accumulation were not affected by isoproterenol. Although isoproterenol decreased the maximal production of 3H-IP stimulated by glutamate, the concentration of glutamate required to produce half-maximal 3H-IP accumulation did not change significantly (Fig. 6) .
Testing other A-kinase-activating agents, we found that forskolin at concentrations between 10 and 100 pM and dBcAMP at concentrations between 10 and 500 pMeach inhibited the ability of glutamate to stimulate 3H-IP accumulation in a concentration-dependent manner (Table 1) . Basal 3H-IP formation was not inhibited by either of these agents. Inclusion of the protein kinase inhibitors HA-1004 or H-7 in the medium (Hidaka et al., 1984; Yada et al., 1989 ) each significantly reduced the inhibition of glutamate-stimu- . , . , . , . , . Glutamate UM) To investigate the site at which cyclic AMP inhibits PPI hydrolysis, astrocytes were first exposed to dBcAMP for 10 min, then permeabilized with digitonin, and exposed to agonists. This exposure to dBcAMP resulted in a concentration-dependent inhibition of 3H-IP release from the permeabilized cells on stimulation by GTP[S] as well as by glutamate plus GTP [S] (Fig. 7) . dBcAMP also inhibited glutamateand glutamate plus GTP[S]-stimulated 3H-IP release when it was added simultaneously with the agonist after permeabilization of the cells (85-95% of the inhibition observed in the pretreated cells; data not shown). Pretreatment for 10 min with 100 pMisoprotereno1 or 100 pM forskolin inhibited 3H-IP release by glutamate, GTP[S], or glutamate plus GTP [S] in the permeabilized cells as well (Fig. 8) . As with the inhibition produced by dBcAMP in the permeabilized cells, isoproterenol and forskolin did not affect basal 'H-IP formation. Nor did dBcAMP, forskolin, or isoproterenol inhibit the modest release of 3H-IP produced by elevating the Ca2+ concentration alone (data not shown).
However, in the permeabilized cells, 'H-IP release stimulated by bradykinin, by carbachol, or by either in combination with GTP[S] was inhibited by isoproterenol, forskolin, and dBcAMP (data not shown).
DISCUSSION
Two principal findings resulted from the present study. First, in a permeabilized cell system, we found evidence to support the proposal that a G, protein mediates the metabolism of PPI lipids in astrocytes and that glutamate-stimulated PPI hydrolysis is mediated through this G, protein and is dependent on the concentration of free Ca2+. Second, we determined that the inhibition of glutamate-stimulated PPI hydrolysis by agents that elevate cyclic AMP levels or by analogues capable of activating A-kinase appears to occur at a postreceptor site, at or distal to this G, protein.
Stimulation of the release of 3H-IP by GTP[S] alone in permeabilized astrocytes suggests involvement of the G, protein in the signal transduction process (Cockcroft and Gomperts, 1985) . The coupling of glutamate receptors to phospholipase C by this putative G, protein is supported both by the synergistic stimulation of 3H-IP formation in the combined presence of glutamate and GTP [S] and by the inhibition of glutamate-stimulated PPI hydrolysis by GDPpS at virtually the same K i as it inhibits GTP[S]-stimulated PPI turnover (Fig.   3) . The inhibition by GDPBS suggests that guanine nucleotides remain in astrocytes after permeabilization and are necessary for the receptor-stimulated hydrolysis of PPI lipids by glutamate mediated through a Gp protein. Glutamate-stimulated, G, protein-mediated phospholipase C activity in astrocytes is also sensitive to the concentration of free Ca2+ (Fig. 4) . Significant enhancement of PPI hydrolysis in the combined presence of glutamate and GTP[S] occurred at free Ca2' concentrations as low as 14-39 nM, a result supporting the proposal that a G, protein could potentiate glutamate-stimulated signal transduction at concentrations of Ca2+ likely to be encountered in quiescent cells. Potentiation was greatest, however, at higher concentrations of Ca2+. Moreover, Pearce et al. ( 1986~) showed in 45Ca2+ efflux studies that the intracellular Ca2+ concentration probably does rise in astrocytes on stimulation by glutamate and that PPI turnover is partially dependent on extracellular calcium, a finding suggesting that the elevation of Ca2+ level above basal values plays some role in phospholipase C activation in astrocytes. To what concentration free Caz+ actually rises and influences G, protein-mediated phospholipase C activity in intact astrocytes, however, remains to be determined.
Glutamate-stimulated 'H-IP formation in astrocytes is inhibited by @-adrenergic receptor stimulation (Fig.  6) , which elevates cyclic AMP levels in astrocytes (McCarthy and de Vellis, 1978) ; by forskolin (Table  I) , a diterpene that directly activates adenyl cyclase (Seamon and Daly, 1986) ; and by the cyclic AMP analogue dBcAMP (Table 1) . Thus, activation of A-kinase; which occurs with all of these agents, seems likely to be the critical step in mediating the inhibition and is in agreement with the inhibition of PPI turnover on elevation of cyclic AMP levels by various mechanisms in other cellular systems (Takenawa et al., 1986; Francel et al., 1987; Paris and Pouyssegur, 1987; Puurunen et al., 1987; Ritchie et al., 1987; Guillon et al., 1988; Madison and Brown, 1988; Windebank et al., 1988; Akil and Fisher, 1989; Yada et al., 1989) .
Moreover, the effect of dBcAMP, isoproterenol, or forskolin on glutamate-stimulated PPI turnover was prevented in the presence of the protein kinase inhibitors HA-1004 and H-7. A complete block of the cyclic AMP-mediated inhibition by HA-1004 at a concentration (3 p M ) well below its Ki for protein kinase C (40 p M ) (Hidaka et al., 1984) further supports the proposal that the cyclic AMP-mediated inhibition occurs through an A-kinase dependent mechanism, consistent with a similar response of platelets (Yada et al., 1989) .
Several findings of the present study provide evidence that localizes the point in the PPI pathway at which the cyclic AMP-dependent mechanisms might interfere. The concentration of glutamate required to produce half-maximal stimulation was not significantly altered by isoproterenol (Fig. 6) , a finding indicating that cyclic AMP-mediated inhibition does not change the agonist's affinity for its receptor.
Moreover, in the permeabdized astrocytes, dBcAMP, isoproterenol, and forskolin each inhibited postreceptor GTP[S]-stimulated PPI hydrolysis, as well as the stimulation potentiated by GTP [S] in the presence of glutamate (Figs. 7 and 8) . These results point to the G, protein or its interaction with phospholipase C as the site of inhibition by cyclic AMP, rather than at the receptor or its coupling to the G, protein. Our results do not eliminate the possibility that cyclic AMP could also affect glutamate receptor number but preclude that inhibition could occur exclusively by this mechanism, because GTP[S]-stimulated 'H-IP release, which bypasses the receptor, was inhibited. Consistent with our findings, postreceptor sites of inhibition were suggested by other studies, as well, in platelets (Lazarowski and Lapetina, 1989; Yada et al., 1989 ) and in SK-N-SH neuroblastoma cells (AkiI and Fisher, 1989) .
This study did not identify the specific A-kinase substrate($ that might inhibit PPI turnover in astrocytes. The G, protein itself is a possibility, as are enzymes that regulate the availability of substrates for hydrolysis by phospholipase C. Phosphorylation of phospholipase C seems unlikely in our cells, because neither the agents elevating cyclic AMP levels nor dBcAMP inhibited basal 'H-IP formation in intact or in permeabilized astrocytes. This is unlike conclusions in C6Bu 1 cells, in which 8-bromo cyclic AMP modestly inhibited both basal and agonist-stimulated 'H-IP formation simultaneously with phosphorylation of one isoenzyme of phospholipase (Kim et al., 1989) , a finding suggesting that alteration of phospholipase C could be the inhibitory mechanism in these cells, Moreover, the fact that dBcAMP and forskolin in astrocytes had no effect on the modest 'H-IP release stimulated by increasing the free Ca2+ concentration (data not shown), which presumably activates phospholipase C, makes a direct effect on this enzyme less likely as well.
In summary, our results indicate that elevation of intracellular cyclic AMP levels inhibits PPI lipid hydrolysis in astrocytes and provides evidence that this occurs by an A-kinase-dependent mechanism, acting at or distal to the G, protein linked to phospholipase C activation in these cells. The observation that these effects occur on receptor-stimulated activation of PPI turnover and receptor-stimulated elevation of cyclic AMP levels suggests that this cross-talk could have physiologic relevance to the function of astrocytes in vivo.
